Amplifica Holdings Group

Amplifica is a rapidly emerging biopharmaceutical company focused on developing new therapies to address androgenetic alopecia (hair loss). It is estimated that more than 50 million men and 30 million women in the United States alone are affected by this condition. The company employs a nature-inspired scientific approach, utilizing molecular mechanisms to regenerate natural hair. Amplifica has identified and isolated unique signaling molecules that stimulate hair follicles to regrow hair. The company will initiate clinical trials to evaluate the safety and efficacy of its core technology and obtain all applicable regulatory approvals.